DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 40 filers reported holding DICE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,268,857 | +62.2% | 371,693 | 0.0% | 14.83% | +68.5% |
| Q1 2023 | $10,649,004 | -8.2% | 371,693 | 0.0% | 8.80% | +4.8% |
| Q4 2022 | $11,596,822 | +2.7% | 371,693 | -33.2% | 8.40% | +25.3% |
| Q3 2022 | $11,290,000 | +30.7% | 556,693 | 0.0% | 6.70% | +19.7% |
| Q2 2022 | $8,640,000 | -18.9% | 556,693 | 0.0% | 5.60% | +6.6% |
| Q1 2022 | $10,650,000 | -24.4% | 556,693 | 0.0% | 5.25% | +2.8% |
| Q4 2021 | $14,090,000 | -22.7% | 556,693 | 0.0% | 5.10% | -2.9% |
| Q3 2021 | $18,232,000 | – | 556,693 | – | 5.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|